Department of Hepatobiliary Surgery and Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Ann Surg. 2021 Dec 1;274(6):e1187-e1195. doi: 10.1097/SLA.0000000000003788.
To determine the prognostic implication of the number and station of LNM, and the minimal number of LNs needed for evaluation to accurately stage patients with intrahepatic cholangiocarcinoma (ICC).
Impact of the number and station of LNM on long-term survival, and the minimal number of LNs needed for accurate staging of ICC patients remain poorly defined.
Data on patients who underwent curative-intent resection for ICC was collected from 15 high-volume centers worldwide. External validation was performed using the SEER registry. Primary outcomes included overall (OS), disease-specific, and recurrence-free survival.
Among 603 patients who underwent curative-intent resection, median and 5-year OS were 30.6 months and 30.4%. Patients with 1 or 2 LNM had comparable worse OS versus patients with no nodal disease (median OS, 1 LNM 18.0, 2 LNM 20.0 vs no LNM 45.0 months, both P < 0.001), yet better OS versus patients with 3 or more LNM (median OS, 1-2 LNM 19.8 vs ≥3 LNM 16.0 months, P < 0.01). On multivariable analysis, a proposed new nodal staging with N1 (1-2 LNM) (Ref. N0, HR 2.40, P < 0.001) and N2 (≥3 LNM) [Ref. N0, hazard ratio (HR) 3.85, P < 0.001] categories were independently associated with incrementally worse OS. Patients with no nodal metastasis, 1-2 LNM and ≥3 LNM also had an increasingly worse disease-specific survival, and recurrence-free survival (both P < 0.05). Total number of LNs examined ≥6 had the greatest discriminatory power relative to OS among patients with 1-2 LNM, and patients with ≥3 LNM in both the multi-institutional (area under the curve 0.780) and SEER database (area under the curve 0.820) (n = 1036). Among patients who underwent an adequate regional lymphadenectomy (total number of LNs examined ≥6), LNM beyond the HDL was associated with worse OS versus LNM within the HDL only (median OS, 14.0 vs 24.0 months, HR 2.41, P = 0.003).
Standard lymphadenectomy of at least 6 LNs is strongly recommended and should include examination beyond station 12 to have the greatest chance of accurate staging. The proposed new nodal staging of N0, N1, and N2 should be considered to stratify outcomes among patients after curative-intent resection of ICC.
确定 LNM 的数量和部位以及评估所需的最小 LNM 数量对肝内胆管癌(ICC)患者进行准确分期的预后意义。
LNM 的数量和部位对长期生存的影响,以及 ICC 患者准确分期所需的最小 LNM 数量仍未得到明确界定。
从全球 15 个大容量中心收集了接受根治性切除治疗 ICC 的患者的数据。使用 SEER 登记处进行外部验证。主要结果包括总生存期(OS)、疾病特异性生存期和无复发生存期。
在接受根治性切除的 603 名患者中,中位和 5 年 OS 分别为 30.6 个月和 30.4%。与无淋巴结疾病的患者相比,1 或 2 个 LNM 的患者 OS 更差(中位 OS,1 个 LNM 为 18.0 个月,2 个 LNM 为 20.0 个月,均 P < 0.001),但与 3 个或更多 LNM 的患者相比 OS 更好(中位 OS,1-2 个 LNM 为 19.8 个月,≥3 个 LNM 为 16.0 个月,均 P < 0.01)。多变量分析显示,提出的新淋巴结分期 N1(1-2 个 LNM)(参考 N0,HR 2.40,P < 0.001)和 N2(≥3 个 LNM)[参考 N0,风险比(HR)3.85,P < 0.001]类别与 OS 逐渐恶化独立相关。无淋巴结转移、1-2 个 LNM 和≥3 个 LNM 的患者疾病特异性生存率和无复发生存率也逐渐恶化(均 P < 0.05)。在接受 1-2 个 LNM 的患者中,与 OS 相比,检查的 LNM 总数≥6 具有最大的鉴别能力,在多机构(曲线下面积 0.780)和 SEER 数据库(曲线下面积 0.820)中,≥3 个 LNM 的患者也具有更大的鉴别能力(n = 1036)。在接受充分区域淋巴结清扫术(检查的 LNM 总数≥6)的患者中,与仅肝内 LNM 相比,肝外 LNM 与较差的 OS 相关(中位 OS,14.0 与 24.0 个月,HR 2.41,P = 0.003)。
强烈推荐至少进行 6 个 LNM 的标准淋巴结清扫术,并且应该包括 12 区以外的检查,以最大程度地提高准确分期的机会。应考虑提出的新的 N0、N1 和 N2 淋巴结分期,以分层 ICC 根治性切除术后患者的结局。